Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.

Journal of medical imaging and radiation oncology - 1 Dec 2017

Tiwari Ankita, Shah Nalini, Sarathi Vijaya, Malhotra Gaurav, Bakshi Ganesh, Prakash Gagan, Khadilkar Kranti, Pandit Reshma, Lila Anurag, Bandgar Tushar

Abstract excerpt

INTRODUCTION: Although few studies have demonstrated utility of 18 F- fluoro-2-deoxy-d-glucose positron emission tomography/computerised tomography (18 F-FDG PET/CT) in benign pheochromocytoma/paragangliomas (PCC/PGLs), there limited data on factors predicting the FDG uptake in PCC/PGL. METHODS: The study was conducted at a tertiary health care centre. In addition to the routine investigations, all patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluorodeoxyglucose F18
Share to Adrenal Gland Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Paraganglioma

Share to Pheochromocytoma

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 28585398
DOI: 10.1111/1754-9485.12620

Genes

RET
SDHB
SDHC
SDHD
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.PMID 28585398Read ↗

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Modern PET imaging for paragangliomas: relation to genetic mutations.Semantic proximity Read ↗

PET detectives: Molecular imaging for phaeochromocytomas and paragangliomas in the genomics eraSemantic proximity Read ↗

Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.Semantic proximity Read ↗

Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.Semantic proximity Read ↗

Metastatic paraganglioma.Semantic proximity Read ↗

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and ImagingSemantic proximity Read ↗

Metastatic pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Genetic Determinants of Pheochromocytoma and Paraganglioma Imaging Phenotypes.Semantic proximity Read ↗

Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.Semantic proximity Read ↗

Molecular imaging in hereditary succinate dehydrogenase mutation-related paragangliomas.Semantic proximity Read ↗

18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.